PHI with breast cyst excision
How does this condition affect your private health insurance?
Mammazystenentfernung, or breast cyst removal, is a procedure to address fluid-filled sacs within the breast tissue. These cysts are extremely common, usually benign, and often part of fibrocystic breast changes. Removal is typically considered when cysts are symptomatic (causing pain or discomfort), large, or when their nature is uncertain despite imaging. The most common methods include fine-needle aspiration, where fluid is drained, or surgical excision for persistent, solid, or suspicious lesions. While the procedure itself treats the immediate cyst, recurrence is possible. The primary goal is symptom relief and to definitively rule out malignancy, though most cysts pose no cancer risk.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 5%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months; symptoms preceding diagnosis or intervention can be acute or chronic.
Duration of Illness (Lifetime)
Often a recurring issue for individuals prone to cysts, though a specific removal is a discrete event. Many women experience multiple cysts over their lifetime.
Cost of Treatment (Initial)
Highly variable: $200-$1000 for aspiration; $2,000-$10,000+ for surgical excision, depending on location and healthcare system.
Cost of Treatment (Lifetime)
Can accumulate if multiple procedures are required for recurrent cysts, potentially reaching several thousand to tens of thousands of dollars.
Mortality Rate
Extremely low (<0.01%), primarily associated with general anesthesia risks for surgical excision rather than the procedure itself.
Risk of Secondary Damages
Low (5-15%): includes temporary pain, bruising, infection, or scarring (for surgical removal). Minor psychological distress from anxiety can also occur.
Probability of Full Recovery
High (over 95%) for the specific treated cyst. However, new cysts can develop or existing ones recur, meaning lifelong freedom from cysts is not guaranteed.
Underlying Disease Risk
Low (<5%) for the cyst itself being malignant. However, cysts often occur within the context of fibrocystic breast changes, a benign condition. Other benign or malignant breast conditions may coexist and be identified during investigation.